More Articles on

FDA

Tagged Articles

November 02, 2022

COVID-19 Vaccine: Novavax Booster Authorized

On October 19, the FDA amended the Novavax COVID-19 Vaccine, Adjuvanted emergency use authorization to authorize the use of a first booster dose for patients 18 years and older: